Found: 9
Select item for more details and to access through your institution.
An FHA domain-mediated protein interaction network of Rad53 reveals its role in polarized cell growth.
- Published in:
- Journal of Cell Biology, 2006, v. 175, n. 5, p. 743, doi. 10.1083/jcb.200605081
- By:
- Publication type:
- Article
Development and initial clinical testing of a multiplexed circulating tumor cell assay in patients with clear cell renal cell carcinoma.
- Published in:
- Molecular Oncology, 2021, v. 15, n. 9, p. 2330, doi. 10.1002/1878-0261.12931
- By:
- Publication type:
- Article
Clinical Implementation of <sup>177</sup>Lu-PSMA-617 in the United States: Lessons Learned and Ongoing Challenges.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 3, p. 349, doi. 10.2967/jnumed.122.265194
- By:
- Publication type:
- Article
A Phase II Trial of Selinexor, an Oral Selective Inhibitor of Nuclear Export Compound, in Abiraterone‐ and/or Enzalutamide‐Refractory Metastatic Castration‐Resistant Prostate Cancer.
- Published in:
- Oncologist, 2018, v. 23, n. 6, p. 656, doi. 10.1634/theoncologist.2017-0624
- By:
- Publication type:
- Article
A Phase I Study of Abiraterone Acetate Combined with BEZ235, a Dual PI3K/mTOR Inhibitor, in Metastatic Castration Resistant Prostate Cancer.
- Published in:
- Oncologist, 2017, v. 22, n. 5, p. 503, doi. 10.1634/theoncologist.2016-0432
- By:
- Publication type:
- Article
PET probes for distinct metabolic pathways have different cell specificities during immune responses in mice.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Phase II trial of CV301 vaccine combined with atezolizumab in advanced urothelial carcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 3, p. 775, doi. 10.1007/s00262-022-03274-6
- By:
- Publication type:
- Article
Checkpoint kinase inhibitor synergizes with DNA-damaging agents in G<sub>1</sub> checkpoint-defective neuroblastoma.
- Published in:
- International Journal of Cancer, 2011, v. 129, n. 8, p. 1953, doi. 10.1002/ijc.25842
- By:
- Publication type:
- Article
A model combining clinical and genomic factors to predict response to PD-1/PD-L1 blockade in advanced urothelial carcinoma.
- Published in:
- 2020
- By:
- Publication type:
- journal article